Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

  3,038,103      
Direct Value   $228,247,061    

Indirect Value

  $11,224,701      
Total Shares   11,753,651      
Total Value   $239,471,762      


Volcano Corp
 $0 Cadence Pharmaceuticals Inc
 $0 Orexigen Therapeutics, Inc.
 $48 Alimera Sciences Inc
 $1,095,234 Clovis Oncology, Inc.
 $661 Glaukos Corp
 $227,151,118 Volcano Corp
 $0 Cadence Pharmaceuticals Inc
 $0 Orexigen Therapeutics, Inc.
 $48 Alimera Sciences Inc
 $1,095,234 Clovis Oncology, Inc.
 $661 Glaukos Corp
 $227,151,118
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-02-20 4 AS $5.01 $170 D/D (34) 42,949 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-01 4 AS $5.01 $38,251 D/D (7,635) 2,509,130 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-01 4 AS $5.01 $117,975 D/D (23,548) 7,738,640 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-01 4 AS $5.01 $651 D/D (130) 42,819 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-01 4 AS $5.01 $1,268 D/D (253) 82,928 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-04 4 AS $5.01 $441 D/D (88) 42,731 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-04 4 AS $5.01 $852 D/D (170) 82,758 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-04 4 AS $5.01 $25,776 D/D (5,145) 2,503,985 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-04 4 AS $5.01 $79,484 D/D (15,865) 7,722,775 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-05 4 AS $5.01 $671 D/D (134) 82,624 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-05 4 AS $5.01 $20,235 D/D (4,039) 2,499,946 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-05 4 AS $5.01 $346 D/D (69) 42,662 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-05 4 AS $5.01 $62,395 D/D (12,454) 7,710,321 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-06 4 AS $5.06 $19,425 D/D (3,839) 2,496,107 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-06 4 AS $5.06 $329 D/D (65) 42,597 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-06 4 AS $5.06 $59,915 D/D (11,841) 7,698,480 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-06 4 AS $5.06 $643 D/D (127) 82,497 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-07 4 AS $5.22 $66,299 D/D (12,701) 2,483,406 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-07 4 AS $5.22 $2,192 D/D (420) 82,077 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-07 4 AS $5.22 $204,457 D/D (39,168) 7,659,312 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-07 4 AS $5.22 $1,122 D/D (215) 42,382 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-08 4 AS $5.32 $910 D/D (171) 81,906 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-08 4 AS $5.32 $84,545 D/D (15,892) 7,643,420 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-08 4 AS $5.32 $468 D/D (88) 42,294 0 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2013-03-08 4 AS $5.32 $27,419 D/D (5,154) 2,478,252 0 -

  282  Records found
  1   2   3   4   5  6   7   8   9   10   11   12      
  Page 5 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed